Business Association Chemistry Pharma Life Sciences
Dossiers - Relations with the EU

Overview and position on relations with the EU

Dossiers - Relations with the EU

25 years of bilateral agreements: a model of success for Switzerland

Dossiers - Relations with the EU

Guest article Allnews: Director Stephan Mumenthaler

Dossiers - Relations with the EU

Full association to Horizon Europe essential

Dossiers - Relations with the EU

Interview by NZZ: Matthias Leuenberger, President scienceindustries

Dossiers - Relations with the EU

30 Years EU Single Market: Significance for Switzerland

Dossiers - Relations with the EU

What happens after the failed negotiations on the (InstA)?

Dossiers - Antibiotic resistance

Action plan: One Health approach to combating antimicrobial resistance

Dossiers - Antibiotic resistance

Overview and position on antibiotic resistance

Dossiers - Antibiotic resistance

Promoting research into new antibiotics - but how?

Dossiers - Antibiotic resistance

Containing resistances: Antibiotic monitoring in veterinary medicine

Dossiers - Chemicals regulation

Science-based regulation for a sustainable future

Dossiers - Chemicals regulation

PFAS regulation in Switzerland: Learning from European experiences

Dossiers - Chemicals regulation

PFAS regulation in Switzerland: Not faster, but better

Dossiers - Chemicals regulation

Differentiated view of "risk versus hazard"

Dossiers - Chemicals regulation

Export bans: International solutions instead of solo national efforts

Close
Industry ticker

Newsletter subscription

scienceindustries News
Standpoints
Point
 
 

Foreign trade statistics chemistry pharma life science

Further analyzes

Export Chemicals Pharma Life Sciences Switzerland by region

Further analyzes